Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.


Journal Article

Heparin is considered necessary during percutaneous coronary interventions; however, heparin is contraindicated in patients with heparin-induced thrombocytopenia and/or heparin antibodies. We describe the successful use of the heparinoid Orgaran (danaparoid sodium) in addition to abciximab (ReoPro) in a patient with heparin antibodies who required rotational atherectomy.

Full Text

Cited Authors

  • Hale, LP; Smith, K; Braden, GA; Owen, J

Published Date

  • November 1998

Published In

Volume / Issue

  • 45 / 3

Start / End Page

  • 318 - 322

PubMed ID

  • 9829897

Pubmed Central ID

  • 9829897

International Standard Serial Number (ISSN)

  • 0098-6569

Digital Object Identifier (DOI)

  • 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>;2-2


  • eng